Diabetes Clinical Trials in Tennessee

Showing 61-80 of 596 trials

Effects of My Diabetes Care on Patient Outcomes

NCT05451914

The purpose of this study is to conduct a two-arm, parallel-design, pragmatic randomized controlled trial of a patient portal intervention for diabetes, My Diabetes Care (MDC), to evaluate its effect on clinical outcomes.

Diabetes Mellitus, Type 2

Vanderbilt University Medical Center458 participantsStarted Jul 2023

Boston, Massachusetts, United States • Nashville, Tennessee, United States

Enrolling By Invitation29 miles

Multicenter Assessment of the Pancreas in Type 1 Diabetes

NCT03585153

The overall goal of this research is to develop and validate standard operating procedures (SOP) to assess the human pancreas in individuals with type 1 diabetes (T1D) and other forms of diabetes using advanced, quantitative magnetic resonance imaging (MRI) approaches.

Diabetes Mellitus

Vanderbilt University Medical Center250 participantsStarted Feb 2014

Aurora, Colorado, United States • Chicago, Illinois, United States • Nashville, Tennessee, United States +2 more locations

Not Yet RecruitingPhase 229 miles

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

NCT07142252

This Phase 2 study is a 2-arm, multi-center, double-masked, placebo-controlled, 2:1 randomized sequential trial design in new onset T1D participants (within 100 days of diagnosis). Participants will be administered rezpegaldesleukin/placebo once every 14 days over 26 weeks with an additional 6-month follow-up period.

Type 1 Diabetes Mellitus

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)66 participantsStarted Nov 2025

Nashville, Tennessee, United States

Effects of My Diabetes Care on Patient Outcomes

Multicenter Assessment of the Pancreas in Type 1 Diabetes

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Diabetes Trials in Other Cities

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

OP5-005 Using Omnipod 5 in Adults With Type 2

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes

Omnipod 5 System Compared to Pump Therapy

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

HLA Demographics Study in Adults With Type 1 Diabetes

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Other Conditions in Tennessee